抑郁症的遗传马赛克:将多形态与神经可塑性和压力调节联系起来
Aneta Bednářová1, Emma Szilassyová1, Dominika Jarčušková2
12nd Department of Psychiatry, Faculty of Medicine, Pavol Jozef Šafárik University and Louis Pasteur University Hospital, Rastislavova 43, 04190 Košice, Slovakia.
Pharmaceuticals (Basel, Switzerland)
|February 27, 2026
概括
遗传变异影响主要抑郁症 (MDD) 风险和治疗. 本综述综合了SLC6A4和BDNF等基因的证据,探索它们在神经可塑性和HPA轴调节中的作用,以提供个性化的MDD护理.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 精神病学是一个精神病学.
背景情况:
- 大型抑郁症 (MDD) 的起源复杂,涉及环境因素和显著的遗传倾向.
- 遗传多态性与MDD易感性,进展和治疗结果有关,尽管研究结果在不同人群中存在差异.
- 了解这些遗传基础对于开发有效的干预措施至关重要.
研究的目的:
- 审查和综合有关与MDD相关的遗传变异的现有证据.
- 要突出复制良好的遗传发现,并将其与探索性发现区分开来.
- 讨论这些遗传见解的生物相关性和潜在的临床应用.
主要方法:
- 关于遗传变异和MDD的现有文献的叙述性综述.
- 专注于关键的神经递质和应激反应通路.
- 对包括SLC6A4,BDNF,COMT,FKBP5,CRHR1,MAOA,TPH2和FTO在内的基因的评估.
主要成果:
- 血清激素,神经营养,多巴胺和应激反应系统中的几种遗传变异与MDD有关.
- 像SLC6A4和BDNF这样的基因中的特定变异显示了复制的关联.
- 新出现的证据表明,MAOA,TPH2和FTO等基因与MDD有关.
结论:
- 遗传因素,包括多基因和表观遗传相互作用,对MDD的复杂性和临床异质性作出了重大贡献.
- 了解遗传变异的生物相关性 (神经可塑性,神经传递,HPA轴) 是关键.
- 这些知识为MDD的个性化诊断,预后和治疗策略提供了潜力.
相关概念视频
Human Genetics
1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
Depressive Disorders: Etiology
793
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
793
Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Stress and Mental Health
1.0K
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
1.0K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
63
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
63


